Themis Medicare Ltd

Themis Medicare Capital Structure Change

Themis Medicare Ltd withdrew its proposed preferential issue of 45,95,795 warrants. The company secured working capital through alternative means, and no adverse impact is expected.

Themis Medicare Dividend

Themis Medicare fixed the record date as September 23, 2026, for its final dividend FY 2025-26, pending AGM approval on September 30, 2026. No dividend per-share amount is stated.

Themis Medicare Annual General Meeting

Themis Medicare Limited has issued the notice for its upcoming Annual General Meeting scheduled for September 30, 2026. Shareholders will consider resolutions including dividend declaration.

Themis Medicare Annual Report

Themis Medicare Limited has filed its Annual Report for the financial year 2025-26, along with the notice for its 56th Annual General Meeting.

Themis Medicare Price Movement Clarification

Themis Medicare Limited has clarified to the exchange that there is no pending or delayed material information regarding the recent increase in trading volume.

Themis Medicare Investor Presentation: Key Takeaways

Themis Medicare Q1 FY27 revenue hit ₹86.96 Cr with 28.3% PAT margin, significantly boosted by one-off gains of ₹92.95 Cr from share sales.

Themis Medicare Q1 FY27 Results: Turns Profitable, Net Profit ₹24.6 Cr

Themis Medicare Ltd reported revenue from operations of ₹87 Cr (-10.9% YoY) and net profit of ₹24.6 Cr for Q1 FY27.

Key figure

Net profit ₹24.6 Cr

Themis Medicare Earnings Call: Key Takeaways

Themis Medicare reported Q4 FY26 recovery with ₹76.5cr revenue (up 6.7% YoY) and ₹8.9cr PAT, transitioning from a loss. Strategy focuses on Hospital business growth and API expansion.

Themis Medicare Q4 FY26 Results: Turns Profitable, Net Profit ₹8.9 Cr

Themis Medicare Ltd reported revenue from operations of ₹76.5 Cr (+6.7% YoY) and net profit of ₹8.9 Cr for Q4 FY26.

Key figure

Net profit ₹8.9 Cr